DiaMedica Therapeutics Inc. (DMAC) vs NRC Health (NRC)
A side-by-side comparison of DiaMedica Therapeutics Inc. and NRC Health across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMAC
DiaMedica Therapeutics Inc.
$8.25HealthcareDelayed quote: Oct 6, 2026, 10:34 AM EDT
NRC
NRC Health
$20.22HealthcareDelayed quote: Oct 6, 2026, 10:29 AM EDT
Total return — DMAC vs NRC
growth of $100 · dividends reinvested · last 10yDMAC +113.7% (+7.9%/yr)NRC +58.9% (+4.7%/yr)DMAC compounded faster over this window
DMAC NRC
DMAC vs NRC: by the numbers
- •NRC is the larger company ($456M vs $444M market cap).
- •NRC is profitable (4.18% net margin) while DMAC runs a net loss (0.00%).
- •NRC pays a dividend (2.89% yield), while DMAC has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | DMAC | NRC |
|---|---|---|
| P/E ratio | N/A | 80.11 |
| Forward P/E | N/A | 22.98 |
| P/S ratio | N/A | 3.26 |
| P/B ratio | 11.59 | 69.58 |
| EV / EBITDA | N/A | 23.21 |
| FCF yield | N/A | 4.75% |
Profitability
| Metric | DMAC | NRC |
|---|---|---|
| Gross margin | 0.00% | 56.33% |
| Operating margin | 0.00% | 10.53% |
| Net margin | 0.00% | 4.18% |
| ROE | -97.92% | 89.43% |
| ROIC | -100.87% | 8.75% |
Dividends
| Metric | DMAC | NRC |
|---|---|---|
| Dividend yield | N/A | 2.89% |
| Payout ratio | N/A | 237.72% |
Growth (annualized)
| Metric | DMAC | NRC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -0.02% |
| EPS CAGR (5Y) | N/A | -18.88% |
| FCF CAGR (5Y) | N/A | -14.35% |
| Total return CAGR (5Y) | 16.41% | -11.49% |
Frequently asked
- Does DMAC or NRC pay a bigger dividend?
- NRC pays a dividend (2.89% yield), while DMAC has no payments in the available dividend history.
- Is DMAC or NRC more profitable?
- NRC runs the higher net margin — DMAC at 0.00% versus NRC at 4.18%.
- How have DMAC and NRC total returns compared?
- Over the past 10 years, DMAC delivered 7.89% and NRC delivered 4.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
NRC Health P/E ratioNRC Health dividend yieldDiaMedica Therapeutics ROENRC Health ROEDiaMedica Therapeutics operating marginNRC Health operating marginDiaMedica Therapeutics revenue growthNRC Health revenue growthDiaMedica Therapeutics free cash flowNRC Health free cash flow
DiaMedica Therapeutics & NRC Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.